Randomized Controlled Trial of the SurgDiff Model for Predicting Surgical Difficulty to Help Choose Approach in Mid-Low Rectal Cancer

ConditionRectal Cancer
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorPeking Union Medical College Hospital

About this trial

This study aims to investigate the feasibility of utilizing the SurgDiff surgical difficulty prediction model to assist surgeons in formulating precise surgical plans.

Eligibility criteria

Qualifiers

Pathological examination confirmed a diagnosis of rectal adenocarcinoma; radical surgery is recommended.

The inferior border of the tumor is ≥1 cm from the dentate line and ≤7 cm from the anal verge;

Preoperative staging was assessed in a stage of c/ycT1-3N0-2M0;

The cardiac, pulmonary, hepatic, renal, and other organ functions are adequate, and the patient can tolerate laparoscopic surgery.

Disqualifiers

Intraoperative exploration is unable to achieve R0 resection or preservation of the anus;

Lateral lymph node dissection is required;

Patients with a history of severe mental illness, immune disorders, or those taking hormonal medications;

Any other circumstances in which the investigator deems it inappropriate for inclusion.

Trial design

Treatments tested in this trial

  • AI-assisted decision-making

Treatment groups

68 Participants
are divided into 2 treatment groups

Locations

This trial has no locations